Literature DB >> 23476162

4-Chloro-6-meth-oxy-pyrimidin-2-amine.

Kaliyaperumal Thanigaimani1, Nuridayanti Che Khalib, Suhana Arshad, Ibrahim Abdul Razak.   

Abstract

The title compound, C5H6ClN3O, is essentially planar with a maximum deviation of 0.0256 (11) Å for all non-H atoms. In the crystal, adjacent mol-ecules are linked by a pair of N-H⋯N hydrogen bonds, forming an inversion dimer with an R2(2)(8) ring motif. The dimers are further linked via N-H⋯O hydrogen bonds into an undulating sheet structure parallel to the bc plane.

Entities:  

Year:  2012        PMID: 23476162      PMCID: PMC3588926          DOI: 10.1107/S160053681204528X

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the biological activity of pyrimidine and amino­pyrimidine derivatives, see: Hunt et al. (1980 ▶); Baker & Santi (1965 ▶). For related structures, see: Schwalbe & Williams (1982 ▶); Hu et al. (2002 ▶); Chinnakali et al. (1999 ▶); Skovsgaard & Bond (2009 ▶). For hydrogen-bond motifs, see: Bernstein et al. (1995 ▶). For bond-length data, see: Allen et al. (1987 ▶). For stability of the temperature controller used for the data collection, see: Cosier & Glazer (1986 ▶).

Experimental

Crystal data

C5H6ClN3O M = 159.58 Monoclinic, a = 3.7683 (2) Å b = 16.4455 (2) Å c = 10.7867 (2) Å β = 94.550 (1)° V = 666.36 (4) Å3 Z = 4 Mo Kα radiation μ = 0.50 mm−1 T = 100 K 0.49 × 0.28 × 0.21 mm

Data collection

Bruker SMART APEXII CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2009 ▶) T min = 0.791, T max = 0.904 9524 measured reflections 2436 independent reflections 2266 reflections with I > 2σ(I) R int = 0.016

Refinement

R[F 2 > 2σ(F 2)] = 0.027 wR(F 2) = 0.070 S = 1.06 2436 reflections 100 parameters H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.67 e Å−3 Δρmin = −0.26 e Å−3 Data collection: APEX2 (Bruker, 2009 ▶); cell refinement: SAINT (Bruker, 2009 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 ▶). Click here for additional data file. Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S160053681204528X/is5214sup1.cif Click here for additional data file. Structure factors: contains datablock(s) I. DOI: 10.1107/S160053681204528X/is5214Isup2.hkl Click here for additional data file. Supplementary material file. DOI: 10.1107/S160053681204528X/is5214Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C5H6ClN3OF(000) = 328
Mr = 159.58Dx = 1.591 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 6060 reflections
a = 3.7683 (2) Åθ = 3.8–32.6°
b = 16.4455 (2) ŵ = 0.50 mm1
c = 10.7867 (2) ÅT = 100 K
β = 94.550 (1)°Block, colourless
V = 666.36 (4) Å30.49 × 0.28 × 0.21 mm
Z = 4
Bruker SMART APEXII CCD area-detector diffractometer2436 independent reflections
Radiation source: fine-focus sealed tube2266 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.016
φ and ω scansθmax = 32.6°, θmin = 2.3°
Absorption correction: multi-scan (SADABS; Bruker, 2009)h = −5→5
Tmin = 0.791, Tmax = 0.904k = −24→21
9524 measured reflectionsl = −16→14
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.027Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.070H atoms treated by a mixture of independent and constrained refinement
S = 1.06w = 1/[σ2(Fo2) + (0.0306P)2 + 0.3355P] where P = (Fo2 + 2Fc2)/3
2436 reflections(Δ/σ)max = 0.001
100 parametersΔρmax = 0.67 e Å3
0 restraintsΔρmin = −0.26 e Å3
Experimental. The crystal was placed in the cold stream of an Oxford Cryosystems Cobra open-flow nitrogen cryostat (Cosier & Glazer, 1986) operating at 100.0 (1) K.
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Cl11.11362 (6)0.546310 (13)0.64838 (2)0.01425 (6)
O10.57563 (19)0.80520 (4)0.79576 (6)0.01449 (13)
N10.9448 (2)0.57688 (5)0.87272 (7)0.01299 (14)
N20.6906 (2)0.70257 (5)0.93883 (7)0.01284 (14)
N30.8057 (3)0.59594 (5)1.07440 (8)0.01996 (17)
C10.8338 (2)0.68624 (5)0.72638 (8)0.01284 (15)
H1A0.84370.70750.64480.015*
C20.9490 (2)0.60954 (5)0.76040 (8)0.01137 (14)
C30.8137 (2)0.62570 (5)0.95924 (8)0.01305 (15)
C40.7000 (2)0.73004 (5)0.82415 (8)0.01155 (15)
C50.4336 (3)0.85141 (6)0.89378 (9)0.01568 (16)
H5A0.30730.89920.85830.024*
H5B0.62860.86910.95320.024*
H5C0.26800.81740.93660.024*
H2N30.722 (4)0.6245 (10)1.1281 (15)0.027 (4)*
H1N30.876 (4)0.5475 (10)1.0891 (15)0.023 (4)*
U11U22U33U12U13U23
Cl10.01773 (10)0.01199 (10)0.01346 (10)0.00039 (7)0.00388 (7)−0.00276 (7)
O10.0206 (3)0.0093 (3)0.0136 (3)0.0025 (2)0.0019 (2)0.0013 (2)
N10.0169 (3)0.0103 (3)0.0119 (3)0.0017 (2)0.0022 (2)0.0000 (2)
N20.0170 (3)0.0092 (3)0.0124 (3)0.0018 (2)0.0017 (2)0.0004 (2)
N30.0359 (5)0.0129 (4)0.0119 (3)0.0084 (3)0.0069 (3)0.0022 (3)
C10.0171 (4)0.0105 (3)0.0110 (3)0.0002 (3)0.0014 (3)0.0003 (3)
C20.0128 (3)0.0099 (3)0.0116 (3)−0.0006 (3)0.0018 (3)−0.0018 (3)
C30.0171 (4)0.0103 (3)0.0118 (3)0.0014 (3)0.0020 (3)0.0005 (3)
C40.0130 (3)0.0086 (3)0.0130 (3)−0.0001 (3)0.0004 (3)0.0003 (3)
C50.0176 (4)0.0115 (4)0.0182 (4)0.0029 (3)0.0026 (3)−0.0013 (3)
Cl1—C21.7449 (9)N3—H2N30.828 (16)
O1—C41.3485 (10)N3—H1N30.850 (16)
O1—C51.4393 (11)C1—C21.3743 (12)
N1—C21.3266 (11)C1—C41.4035 (12)
N1—C31.3539 (11)C1—H1A0.9500
N2—C41.3201 (11)C5—H5A0.9800
N2—C31.3584 (11)C5—H5B0.9800
N3—C31.3378 (12)C5—H5C0.9800
C4—O1—C5117.38 (7)N3—C3—N1117.35 (8)
C2—N1—C3114.89 (8)N3—C3—N2117.28 (8)
C4—N2—C3115.86 (8)N1—C3—N2125.37 (8)
C3—N3—H2N3118.7 (11)N2—C4—O1119.46 (8)
C3—N3—H1N3119.1 (11)N2—C4—C1124.50 (8)
H2N3—N3—H1N3122.1 (15)O1—C4—C1116.04 (8)
C2—C1—C4113.28 (8)O1—C5—H5A109.5
C2—C1—H1A123.4O1—C5—H5B109.5
C4—C1—H1A123.4H5A—C5—H5B109.5
N1—C2—C1126.09 (8)O1—C5—H5C109.5
N1—C2—Cl1114.95 (6)H5A—C5—H5C109.5
C1—C2—Cl1118.96 (7)H5B—C5—H5C109.5
C3—N1—C2—C1−0.18 (13)C4—N2—C3—N10.61 (14)
C3—N1—C2—Cl1−179.36 (6)C3—N2—C4—O1178.63 (8)
C4—C1—C2—N1−0.63 (13)C3—N2—C4—C1−1.55 (13)
C4—C1—C2—Cl1178.52 (6)C5—O1—C4—N2−0.73 (12)
C2—N1—C3—N3−179.55 (9)C5—O1—C4—C1179.44 (8)
C2—N1—C3—N20.22 (13)C2—C1—C4—N21.55 (13)
C4—N2—C3—N3−179.62 (9)C2—C1—C4—O1−178.62 (8)
D—H···AD—HH···AD···AD—H···A
N3—H2N3···O1i0.828 (16)2.251 (17)3.0699 (11)170.1 (15)
N3—H1N3···N1ii0.850 (16)2.183 (16)3.0335 (12)180 (2)
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
N3—H2N3⋯O1i 0.828 (16)2.251 (17)3.0699 (11)170.1 (15)
N3—H1N3⋯N1ii 0.850 (16)2.183 (16)3.0335 (12)180 (2)

Symmetry codes: (i) ; (ii) .

  4 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Analogs of tetrahydrofolic acid XXIV. Further observations on the mode of pyrimidyl binding to dihydrofolic reductase and thymidylate synthetase by the 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol type of inhibitor.

Authors:  B R Baker; D V Santi
Journal:  J Pharm Sci       Date:  1965-09       Impact factor: 3.534

3.  Crystallographic and molecular-orbital studies on the geometry of antifolate drugs.

Authors:  W E Hunt; C H Schwalbe; K Bird; P D Mallinson
Journal:  Biochem J       Date:  1980-05-01       Impact factor: 3.857

4.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.